DK4389D0 - Isoxazoler med nootrop virkning - Google Patents

Isoxazoler med nootrop virkning

Info

Publication number
DK4389D0
DK4389D0 DK004389A DK4389A DK4389D0 DK 4389 D0 DK4389 D0 DK 4389D0 DK 004389 A DK004389 A DK 004389A DK 4389 A DK4389 A DK 4389A DK 4389 D0 DK4389 D0 DK 4389D0
Authority
DK
Denmark
Prior art keywords
pct
isoxazoles
nootrop
effect
sec
Prior art date
Application number
DK004389A
Other languages
Danish (da)
English (en)
Other versions
DK4389A (da
Inventor
Angelo Carenzi
Dario Chiarino
David Della Bella
Mauro Napoletano
Alberto Sala
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20590/87A external-priority patent/IT1205015B/it
Priority claimed from IT20589/87A external-priority patent/IT1205014B/it
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of DK4389A publication Critical patent/DK4389A/da
Publication of DK4389D0 publication Critical patent/DK4389D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK004389A 1987-05-20 1989-01-06 Isoxazoler med nootrop virkning DK4389D0 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT20590/87A IT1205015B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
IT20589/87A IT1205014B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
PCT/EP1988/000445 WO1988009330A1 (en) 1987-05-20 1988-05-19 Isoxazoles with nootropic activity

Publications (2)

Publication Number Publication Date
DK4389A DK4389A (da) 1989-01-06
DK4389D0 true DK4389D0 (da) 1989-01-06

Family

ID=26327590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK004389A DK4389D0 (da) 1987-05-20 1989-01-06 Isoxazoler med nootrop virkning

Country Status (10)

Country Link
US (1) US4985428A (ja)
EP (1) EP0317588B1 (ja)
JP (1) JPH02500365A (ja)
AT (1) ATE65997T1 (ja)
AU (1) AU599809B2 (ja)
DE (1) DE3864124D1 (ja)
DK (1) DK4389D0 (ja)
FI (1) FI89266C (ja)
NO (1) NO172120C (ja)
WO (1) WO1988009330A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
ITMI20042187A1 (it) * 2004-11-16 2005-02-16 Zambon Spa Derivati isossazolici per allievare il dolore neiropatico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB938420A (en) * 1961-02-01 1963-10-02 Shionogi & Co Isoxazole derivatives and production thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
EP0317588B1 (en) 1991-08-07
FI89266C (fi) 1993-09-10
NO890245L (no) 1989-01-19
NO172120C (no) 1993-06-09
US4985428A (en) 1991-01-15
EP0317588A1 (en) 1989-05-31
ATE65997T1 (de) 1991-08-15
DK4389A (da) 1989-01-06
WO1988009330A1 (en) 1988-12-01
FI890173A (fi) 1989-01-13
DE3864124D1 (de) 1991-09-12
AU599809B2 (en) 1990-07-26
FI89266B (fi) 1993-05-31
NO172120B (no) 1993-03-01
JPH02500365A (ja) 1990-02-08
FI890173A0 (fi) 1989-01-13
NO890245D0 (no) 1989-01-19
AU1786988A (en) 1988-12-21

Similar Documents

Publication Publication Date Title
NO890408D0 (no) 3-indolpyrodruesyre-derivater og deres farmasoeytiske anvendelse.
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
DK249389A (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
DK0459256T3 (da) Oxazolidiononer
NO853698L (no) I-substituerte tetralinderivater, fremstilling og anvendel se derav.
ATE87476T1 (de) Fluessige orale formulierung.
ATE204752T1 (de) Therapeutische anwendungen von 2',5'- oligoadenylat-derivaten
DK4389D0 (da) Isoxazoler med nootrop virkning
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DK192890A (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
ES510546A0 (es) "procedimiento de preparar derivados de n-(n-metil-rn(n-aminosulfenil disubstituido)carbamoil)oxi)tioacetamidato de s-metilo".
SE8703308D0 (sv) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
DK47988D0 (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
NO890287D0 (no) Fremstilling av beta-laktam-antibiotika.
ES2039255T3 (es) Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.
FI882388A (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
DE3767940D1 (de) Pyranderivate.
FR2604704B1 (fr) Derives de 4-phenylthiazole, procede de preparation et utilisation en therapeutique

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment